1. Ellingwood SS, Cheng A. Biochemical and clinical aspects of glycogen storage diseases. J Endocrinol 2018;238(3):R131-41. https://doi.org/10.1530/joe-18-0120

2. Derks TGJ, Rijn M Van. Lipids in hepatic glycogen storage diseases : pathophysiology , monitoring of dietary management and future directions. J Inherit Metab Dis 2015;38(3):537-43. https://doi.org/10.1007/s10545-015-9811-2

3. D’souza RS, Levandowski C, Slavov D, Graw SL, Allen LA, Adler E, et al. Danon disease clinical features, evaluation, and management. Circ Hear Fail 2014;7(5):843-9. https://doi.org/10.1161/circheartfailure.114.001105

4. Saudubray JM, Van Den Berghe G, Walter JH. Inborn metabolic diseases diagnosis and treatment. Inborn Metab Dis Diagnosis Treat 2012;1-657. https://doi.org/10.1007/978-3-642-15720-2

5. Ballavenuto JMA, de Oliveira JDD, Alves RJ. Glycogen storage disease type i (Von gierke disease): Report of two cases with severe dyslipidemia. Arq Bras Cardiol 2020;114(4):23-6. https://doi.org/10.36660/abc.20190037

6. Chou J, Matern D, Mansfield B, Chen YT. Type I Glycogen Storage Diseases: Disorders of the Glucose-6- Phosphatase Complex. Curr Mol Med 2002;2(2):121-43. https://doi.org/10.2174/1566524024605798

7. Wang DQ, Fiske LM, Carreras CT, Weinstein DA. Natural history of hepatocellular adenoma formation in glycogen storage disease type i. J Pediatr 2011;159(3):442-6. http://dx.doi.org/10.1016/j.jpeds.2011.02.031

8. Kishnani PS, Austin SL, Abdenur JE, Arn P, Bali DS, Boney A, et al. Diagnosis and management of glycogen storage disease type I: A practice guideline of the American College of Medical Genetics and Genomics. Genet Med 2014;16(11):1-29. https://doi.org/10.1038/gim.2014.128

9. Battaglia M, Pollastri P, Ferraro A, Betoni F. The role of ultrasound-guided needle biopsy in the diagnosis of soft-tissue tumors. J Ultrasound 2007;10(2):59-62. https://doi.org/10.1016/j.jus.2007.03.001

10. Borel F, Mueller C. Alpha-1 Antitrypsin Deciency. Humana New York, NY: Humana Press; 2017. pp-278. https://doi.org/10.1007/978-1-4939-7163-3

11. Chou JY, Mansfield BC. The SLC37 Family of Sugar- Phosphate / Phosphate Exchangers. 1st ed. Vol. 73, Exchangers. Elsevier Inc.; 2014. pp357–382. http://dx.doi.org/10.1016/B978-0-12-800223-0.00010-4

12. Dissanayake VH, Jayasinghe JD, Tilakaratna V. A novel mutation in SLC37A4 gene in a Sri Lankan boy with glycogen storage disease type Ib associated with very early onset neutropenia. J Mol Genet Med 2011;05(01):262-3. https://doi.org/10.4172/1747-0862.1000046

13. Sperb-Ludwig F, Pinheiro FC, Bettio Soares M, Nalin T, Ribeiro EM, Steiner CE, et al. Glycogen storage diseases: Twenty-seven new variants in a cohort of 125 patients. Mol Genet Genomic Med 2019;7(11):1-10. https://doi.org/10.1002/mgg3.877

14. Choi R, Park H doo, Ko JM, Lee J, Lee DH, Hong SJ, et al. Novel SLC37A4 Mutations in Korean Patients With Glycogen Storage Disease Ib. Ann Lab Med 2017;37(3):261-6. https://doi.org/10.3343/alm.2017.37.3.261

15. Han SH, Ki CS, Lee JE, Hong YJ, Son BK, Lee KH, et al. A novel mutation (A148V) in the glucose 6-phosphate translocase (SLC37A4) gene in a Korean patient with glycogen storage disease type 1b. J Korean Med Sci 2005;20(3):499-501. https://doi.org/10.3346/jkms.2005.20.3.499

16. Zhang Y, Sun H, Wan N. Mutation analysis of SLC37A4 in a patient with glycogen storage disease-type Ib. J Int Med Res 2019;47(12):5996-6003. https://doi.org/10.1177/0300060519867819

17. Veiga-da-cunha M, Gerin I, Chen Y tsong, Lee PJ, Leonard J V, Schaftingen E Van. The Putative glucose 6-phosphate translocase gene is mutated in essentially all cases of glycogen storage disease type I non-a. Eur J Hum Genet 1999;7(6):717-23. https://doi.org/10.1038/sj.ejhg.5200366